Position Summary: We are seeking an experienced and strategic Director, Assay Development and Biomarkers to lead and drive the development, validation, and implementation of biomarker strategies and associated assays across all stages of drug development
Company Summary: Korro is a biopharmaceutical company developing a new class of genetic medicines using a proprietary RNA editing platform, based in Cambridge, Massachusetts
Key Responsibilities: Develop and execute biomarker strategies aligned with program objectives across all development stages (preclinical, clinical, regulatory, and commercial)
Define and prioritize biomarker hypotheses (PD, prognostic, predictive, safety, response) and guide integration into study designs
Provide expert input into translational and clinical development plans, including end-to-end biomarker plans for IND, CTA, and NDA/MAA submissions
Lead development, optimization, and validation of fit-for-purpose biomarker assays (IHC, ELISA, PCR, NGS, flow cytometry, mass spectrometry, multiplex platforms)
Oversee internal or outsourced assay development and qualification for exploratory clinical trial use (CLIA/CAP, GCLP), and companion diagnostics (IVD)
Ensure assay readiness and quality for clinical trials (sample logistics, CRO/vendor oversight, SOPs, assay tech transfer)
Partner with scientists, clinical teams, and regulatory leads to integrate biomarkers into clinical trial protocols and endpoints
Monitor biomarker data in ongoing studies and provide real-time interpretation to support clinical decisions
Collaborate with biostatistics, bioinformatics, and data science teams for analysis, interpretation, and visualization of biomarker data
Manage external vendors, CROs, and diagnostic partners and represent biomarker strategy at governance meetings and regulatory interactions
Requirements
PhD in Molecular Biology, Immunology, Pharmacology, or related life sciences discipline; MD or MD/PhD preferred
Therapeutic area experience in Liver Diseases, Neurological Disorders, or Rare Diseases
10+ years of experience in biomarker research, translational science, or assay development within the biotech/pharma industry
Proven experience with biomarker strategy and assay development across discovery, clinical, and commercial stages
Demonstrated success working with regulatory agencies on biomarker and CDx-related filings
Experience managing CROs and external diagnostic partners
Deep knowledge of a broad range of assay platforms and technologies
Familiarity with GLP/GCLP, CLIA, and regulatory requirements for biomarker assays
Strong understanding of genomics, proteomics, and data integration
Proven leadership in cross-functional matrix environments
Excellent written and verbal communication skills, including scientific presentation and regulatory writing experience
Strategic thinker with operational excellence and scientific rigor